bpc-157 clinical trial dosing protocol human BPC-157 Dosing (Common Protocols) 🔹 Oral / Subcutaneous • 500 mcg daily • Duration: 6 weeks 🔹 Intramuscular / Peritendinous • 1 mg daily • Duration: 6 weeks ⚠️ Note: Not approved Does BPC 157 Help with

Get Your Personalized Plan Complete a quick survey to help us understand your goals, health history, and preferences

Yes, please call us at 563-424-6400 or click the button to schedule online!

Research published in World Journal of Gastroenterology demonstrates BPC-157's ability to protect and heal the entire gastrointestinal tract, from the esophagus to the colon

B12 helps release energy from food, so a person whose blood levels are genuinely low can feel a real lift once treated

Less PRP means less growth factors, which can mean your results may not be as good as they could have been

Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H, Fellermann K, Ganz T, Stange EF, Bevins CL: Reduced Paneth cell -defensins in ileal Crohn's disease